30th September 2009
CareCapital Group Plc
("CareCapital" or "the Group")
Interim Report for the Six Months to 30 June 2009
CareCapital Group Plc (AIM: CARE), a healthcare real estate developer and investor in the UK and in Germany, is pleased to announce its interim report for the six months to 30 June 2009.
Highlights
Group rental income up 21% to £1,596,719 (HI 2008: £1,312,661)
Adjusted diluted Net Asset Value ("NAV") per share* 18.5p (H1 2008: 22.5p)
Loss before tax of £880,005 (H1 2008 Profit: £20,049)
Development pipeline in the UK and Germany with a combined value of £87 million
*Adjusted diluted net asset per share - excludes deferred tax on property portfolio revaluation. Calculated on a similar basis for 2008.
Dr. Michael Sinclair, Chairman, commented, "I remain convinced that the development of, and investment in, medical office buildings remains one of the most stable long term property related activities and that this will continue to be the case for the foreseeable future. This is reflected by the recent valuation exercises which reinforce the real worth of the Company"
For further information, please contact:
CareCapital Group Plc |
Daniel Stewart & Co. Plc |
Tavistock Communications |
Paul Stacey, Chief Executive Steve Wilden, Finance Director |
Simon Leathers, Corporate Finance |
Simon Hudson Paul Young |
Tel: 020 7034 1949 |
Tel: 020 7776 6550 |
Tel: 020 7920 3150 |
pstacey@carecapital.co.uk swilden@carecapital.co.uk |
simon.leathers@danielstewart.co.uk |
shudson@tavistock.co.uk pyoung@tavistock.co.uk |
Chairman's Statement
I am pleased to present the financial results for the CareCapital Group Plc for the six months to 30 June 2009.
At 30 June 2009 the Group's investment properties and developments in progress were valued at £57.6 million (31.12.08: £55.8 million; 30.6.08: £49.6 million). Adjusted diluted Net Asset Value per share (which excludes deferred tax on property revaluations) was 18.5p at 30 June; (31.12.08: 20.9p). Group rental income for the six months under review was £1.6 million (2008: £1.3 million)
The period under review and the subsequent months to date have presented challenges which your Board has striven to address. The Board's view is that it would not have been in the interests of shareholders to raise funds through the market at a valuation significantly below net asset value. Consequently the Company has to date procured further short term secured borrowings of just under £5 million net of costs of which I have personally provided £4.2 million.
My senior management colleagues and I, as was announced on 6 April 2009, explored the option of a management buy out of the Group. However, the receipt of third party expressions of interest in respect of the acquisition of all or part of the Group resulted in our decision to terminate the management buy out option, as announced on 6 April 2009, in order to ensure no conflict of interest in considering any other financing offers. The Board is currently considering the potential outcome of this process and is evaluating the options for the future direction and status of the Group and its financing requirements.
In order to assess any firm proposals relating to the acquisition of the Group or any part of it, we have engaged, since 30 June 2009, an international firm of chartered surveyors to perform a valuation of the investment property portfolios in the UK and Germany. This report has recently been completed and has produced a gross valuation of the UK Portfolio of £23 million (excluding the Folkestone Dental Centre) and Germany of €26.6 million. This has reinforced the valuation shown in the 2008 Annual Report and Accounts.
Additionally, the Group has a number of projects at advanced stages of development ("the development pipeline"); all of which are currently expected to proceed. Consequently the Directors have commissioned an independent firm of accountants to value the development pipeline. Based on the expected rental values and current rental yields in the sector, this places a residual value (before seller's costs) on the development pipeline in the range of between £8 million and £11.1 million. In arriving at the residual valuation, all future development costs have been deducted and the expected completion dates of the various projects have been taken into account.
If this valuation of the development pipeline were to be incorporated into the Group's assets it would produce an increase in net assets per share of between 10.4p and 14.4 p.
The outcome of these valuation exercises has not been incorporated into the half year financial results.
Development activity and the securing of associated long term debt continues in line with the Board's expectations. As previously reported we completed the development in Marktredwitz, Northern Bavaria, in December 2008 and it was fully tenanted by the end of March 2009. The construction of our second medical office building in Adlershof, South East Berlin is on schedule with completion due before the end of March 2010. This building is fully pre let.
In the UK it is anticipated that the projects in Coventry and Consett will be on site by early November 2009. An unexpected casualty of the present economic conditions has been the dental tenants at Folkestone, who are unable to meet the obligations of the lease. In seeking redress under the terms of the lease compensation has been agreed with one of the guarantors. The Group is actively seeking alternative tenants and as a consequence, the property is valued in the accounts at cost.
I remain convinced that the development of, and investment in, medical office buildings remains one of the most stable long term property related activities and that this will continue to be the case for the foreseeable future.
Dr Michael Sinclair,
Chairman
30th September 2009
CareCapital Group Plc
Consolidated income statement for the six months ended 30 June 2009
|
|
|
|
|
|
Six months |
Six months |
Year |
|
|
|
|
|
|
ended |
ended |
ended |
|
|
|
|
|
|
30 June |
30 June |
31 December |
|
|
|
|
|
|
2009 |
2008 |
2008 |
|
|
|
|
|
|
Unaudited |
Unaudited |
Audited |
|
|
|
|
|
Notes |
£ |
£ |
£ |
|
|
|
|
|
|
|
||
Revenue |
|
|
|
|
|
1,596,719 |
1,312,661 |
2,856,110 |
Cost of sales |
|
|
|
|
(203,817) |
(178,086) |
(416,025) |
|
Gross profit |
|
|
|
|
1,392,902 |
1,134,575 |
2,440,085 |
|
Administrative expenses |
|
|
|
(939,268) |
(802,180) |
(1,750,826) |
||
Net surplus / (deficit) on revaluation of investment properties |
|
|
130,511 |
254,525 |
(1,655,932) |
|||
Operating profit / (loss) |
|
|
|
|
584,145 |
586,920 |
(966,673) |
|
Finance income |
|
|
|
|
676 |
287,537 |
1,208,929 |
|
Finance costs |
|
|
|
|
(1,464,826) |
(874,324) |
(2,548,868) |
|
Change in fair value of financial instruments |
|
|
- |
19,916 |
92,256 |
|||
Net finance costs |
|
|
|
|
(1,464,150) |
(566,871) |
(1,247,683) |
|
(Loss) / Profit before tax |
|
|
|
|
(880,005) |
20,049 |
(2,214,356) |
|
Taxation |
|
|
|
|
|
- |
(76,844) |
524,195 |
(Loss) / Profit on ordinary activities after taxation |
|
(880,005) |
(56,795) |
(1,690,161) |
||||
(Loss) / Profit for the period |
|
|
|
|
|
|
||
- attributable to equity shareholders |
|
|
(905,825) |
(70,966) |
(1,688,027) |
|||
- attributable to minority interests |
|
|
25,820 |
14,171 |
(2,134) |
|||
|
|
|
|
|
|
(880,005) |
(56,795) |
(1,690,161) |
(Loss) / Earnings per Ordinary Share |
|
|
|
|
|
|||
|
|
-Basic |
|
|
5 |
(1.15)p |
(0.09)p |
(2.20)p |
|
|
- Diluted |
|
|
5 |
(1.15)p |
(0.09)p |
(2.20)p |
Weighted average number of shares ('000) |
|
5 |
76,754 |
76,754 |
76,754 |
The above results relate to continuing operations.
CareCapital Group Plc
Statement of comprehensive income for the six months ended 30 June 2009
|
|
|
|
|
Six months
|
Six months
|
Year
|
||
|
|
|
|
|
ended
|
ended
|
ended
|
||
|
|
|
|
|
30 June
|
30 June
|
31 December
|
||
|
|
|
|
|
2009
|
2008
|
2008
|
||
|
|
|
|
|
Unaudited
|
Unaudited
|
Audited
|
||
|
|
|
|
|
£
|
£
|
£
|
(Loss) / Profit for the period |
(880,005) |
(56,795) |
(1,690,161) |
Other comprehensive income: |
|
|
|
|
|
|
|
Exchange differences on translating foreign operations |
(960,581) |
125,978 |
488,168 |
|
|
|
|
Other comprehensive income for the period, net of tax |
(960,581) |
125,978 |
488,168 |
|
|
|
|
Total comprehensive income for the period |
(1,840,586) |
69,183 |
(1,201,993) |
|
|
|
|
|
|
|
|
Total comprehensive income attributable to: |
|
|
|
|
|
|
|
Owners of the parent |
(1,835,362) |
44,885 |
(1,248,676) |
Minority interest |
(5,224) |
24,298 |
46,683 |
|
|
|
|
|
(1,840,586) |
69,183 |
(1,201,993) |
CareCapital Group Plc
Consolidated statement of financial position at 30 June 2009
|
|
|
|
As at |
As at |
As at |
|
|
|
|
30 June |
31 December |
30 June |
|
|
|
|
2009 |
2008 |
2008 |
|
|
|
|
Unaudited |
Audited |
Unaudited |
|
|
|
|
£ |
£ |
£ |
Non - current assets |
|
|
|
|
||
Intangible assets |
|
|
1,751,959 |
1,751,959 |
1,965,615 |
|
Investment properties |
|
|
49,367,932 |
52,331,824 |
41,883,741 |
|
Development properties |
|
8,236,752 |
3,512,716 |
7,703,083 |
||
Leasehold improvements |
|
75,003 |
79,914 |
84,825 |
||
Plant and equipment |
|
|
62,247 |
58,941 |
45,063 |
|
|
|
|
|
59,493,894 |
57,735,354 |
36,294,850 |
Current assets |
|
|
|
|
|
|
Trade and other receivables |
|
314,274 |
465,181 |
632,328 |
||
Cash and cash equivalents |
|
178,216 |
2,519,519 |
245,252 |
||
|
|
492,490 |
2,984,700 |
877,580 |
||
Total assets |
|
|
59,986,384 |
60,720,054 |
52,559,907 |
|
Current liabilities |
|
|
|
|
|
|
Trade and other payables |
|
(2,785,647) |
(1,940,940) |
(1,533,558) |
||
Borrowings, including finance leases |
(4,609,067) |
(4,438,452) |
(3,805,223) |
|||
Derivative financial instruments |
|
- |
- |
(72,340) |
||
Total Current Liabilities |
|
(7,394,713) |
(6,379,392) |
(5,411,121) |
||
Non - current liabilities |
|
|
|
|
||
Borrowings, including finance leases |
(38,408,437) |
(38,327,667) |
(29,434,026) |
|||
Deferred tax provision |
|
(2,103,420) |
(2,103,420) |
(2,704,459) |
||
|
|
|
|
(40,511,857) |
(40,431,087) |
(32,138,485) |
Total liabilities |
|
|
(47,906,571) |
(46,810,479) |
(37,549,606) |
|
Net assets |
|
|
12,079,813 |
13,909,575 |
15,010,301 |
|
Equity |
|
|
|
|
|
|
Share capital |
|
|
767,541 |
767,541 |
767,541 |
|
Share premium account |
|
|
1,397,500 |
1,397,500 |
1,397,500 |
|
Share option reserve |
|
401,430 |
390,606 |
220,156 |
||
Reverse acquisition reserve |
|
11,038,204 |
11,038,204 |
11,038,204 |
||
Exchange movements reserve |
|
(486,133) |
443,404 |
119,904 |
||
Profit and Loss account |
|
(1,209,294) |
(303,469) |
1,313,592 |
||
Equity shareholders interest |
|
11,909,248 |
13,733,786 |
14,856,897 |
||
Minority interest |
|
|
170,565 |
175,789 |
153,404 |
|
Total equity |
|
|
12,079,813 |
13,909,575 |
15,010,301 |
CareCapital Group Plc
Consolidated statement of changes in equity for the six months ended 30 June 2009
|
|
|
Share |
Share |
Share |
Reverse |
Exchange rate |
Profit and |
Equity |
Minority |
Total |
|
|
|
capital |
premium |
options |
acquisition |
movement |
loss account |
Shareholder |
Interest |
|
|
|
|
|
|
reserve |
reserve |
reserve |
|
Interest |
|
|
|
|
|
£ |
£ |
£ |
£ |
£ |
£ |
£ |
£ |
£ |
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
|
|
|
|
|
|
|
|
|
|
1 January 2008 |
|
767,541 |
1,397,500 |
209,332 |
11,038,204 |
4,053 |
1,384,558 |
14,801,188 |
129,106 |
14,930,294 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange rate movement |
|
- |
- |
- |
- |
115,851 |
- |
115,851 |
10,127 |
125,978 |
|
Loss for the period |
|
|
- |
- |
- |
- |
- |
(70,966) |
(70,966) |
14,171 |
(56,795) |
Total recognised income |
|
|
|
|
|
|
|
|
|
||
and expenditure |
|
- |
- |
- |
- |
115,851 |
(70,966) |
44,885 |
24,298 |
69,183 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Share based payment |
|
|
|
|
|
|
|
|
|
||
- employee services |
|
- |
- |
10,824 |
- |
- |
- |
10,824 |
- |
10,824 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
|
|
|
|
|
|
|
|
|
|
30 June 2008 |
|
767,541 |
1,397,500 |
220,156 |
11,038,204 |
119,904 |
1,313,592 |
14,856,897 |
153,404 |
15,010,301 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
|
|
|
|
|
|
|
|
|
|
1 July 2008 |
|
767,541 |
1,397,500 |
220,156 |
11,038,204 |
119,904 |
1,313,592 |
14,856,897 |
153,404 |
15,010,301 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange rate movement |
- |
- |
- |
- |
323,500 |
- |
323,500 |
38,690 |
362,190 |
||
Loss for the period |
|
- |
- |
- |
- |
- |
(1,617,061) |
(1,617,061) |
(16,305) |
(1,633,366) |
|
Total recognised income |
|
|
|
|
|
|
|
|
|
||
and expenditure |
|
- |
- |
- |
- |
323,500 |
(1,617,061) |
(1,293,561) |
22,385 |
(1,271,176) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Share based payment |
|
|
|
|
|
|
|
|
|
||
- employee services |
|
- |
- |
10,825 |
- |
- |
- |
10,825 |
- |
10,825 |
|
costs of raising finance |
|
|
159,625 |
|
|
|
159,625 |
|
159,625 |
||
Balance at |
|
|
|
|
|
|
|
|
|
|
|
31 December 2008 |
|
767,541 |
1,397,500 |
390,606 |
11,038,204 |
443,404 |
(303,469) |
13,733,786 |
175,789 |
13,909,575 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
|
|
|
|
|
|
|
|
|
|
1 January 2009 |
|
767,541 |
1,397,500 |
390,606 |
11,038,204 |
443,404 |
(303,469) |
13,733,786 |
175,789 |
13,909,575 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange rate movement |
- |
- |
- |
- |
(929,537) |
- |
(929,537) |
(31,044) |
(960,581) |
||
Loss for the period |
|
- |
- |
- |
- |
- |
(905,825) |
(905,825) |
25,820 |
(880,005) |
|
Total recognised income |
|
|
|
|
|
|
|
|
|
||
and expenditure |
|
- |
- |
- |
- |
(929,537) |
(905,825) |
(1,835,362) |
(5,224) |
(1,840,586) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Share based payment |
|
|
|
|
|
|
|
|
|
||
- employee services |
|
- |
- |
10,824 |
- |
- |
- |
10,824 |
- |
10,824 |
|
Balance at |
|
|
|
|
|
|
|
|
|
|
|
30 June 2009 |
|
767,541 |
1,397,500 |
401,430 |
11,038,204 |
(486,133) |
(1,209,294) |
11,909,248 |
170,565 |
12,079,813 |
CareCapital Group Plc
Consolidated statement of cash flows for the six months ended 30 June 2009
|
|
|
|
|
|
Six months |
Six months |
Year |
|
|
|
|
|
|
ended |
ended |
ended |
|
|
|
|
|
|
30 June |
30 June |
31 December |
|
|
|
|
|
|
2009 |
2008 |
2008 |
|
|
|
|
|
|
Unaudited |
Unaudited |
Audited |
|
|
|
|
|
|
£ |
£ |
£ |
|
|
|
|
|
|
|
|
|
Cash flows from operating activities |
|
|
|
|
|
|||
(Loss) / Profit after taxation |
|
|
|
(880,005) |
(56,795) |
(1,690,161) |
||
Adjustments |
|
|
|
|
|
|
|
|
Taxation |
|
|
|
|
|
- |
76,844 |
(524,195) |
Change in fair value of financial instruments |
|
|
- |
(19,916) |
(92,256) |
|||
Finance costs |
|
|
|
|
1,464,826 |
874,324 |
2,548,868 |
|
Finance income |
|
|
|
|
(676) |
(287,537) |
(1,208,929) |
|
Unrealised net revaluation gains on investment properties |
|
(130,511) |
(254,525) |
1,655,932 |
||||
Depreciation |
|
|
|
|
13,660 |
21,922 |
38,460 |
|
Write off of development properties |
|
|
69,649 |
- |
16,933 |
|||
Share based payments |
|
|
|
10,824 |
14,432 |
21,649 |
||
Cash flows from operations before changes in working capital |
547,767 |
368,749 |
766,301 |
|||||
Change in trade and other receivables |
|
|
150,907 |
(86,183) |
(13,770) |
|||
Change in trade and other payables |
|
|
890,256 |
724,753 |
808,538 |
|||
Cash (used) / generated from operations |
|
|
1,588,930 |
1,007,319 |
1,561,069 |
|||
Interest paid |
|
|
|
|
(1,252,236) |
(855,991) |
(2,186,557) |
|
Cash flows from operating activities |
|
|
336,694 |
151,328 |
(625,488) |
|||
Cash flows from investing activities |
|
|
|
|
|
|||
Purchase of investment property |
|
|
|
- |
(468,574) |
(520,845) |
||
Capital expenditure on development properties |
|
|
(4,825,697) |
(4,719,491) |
(8,461,421) |
|||
Capital expenditure on leasehold improvements |
|
|
- |
(400) |
(400) |
|||
Purchase of plant and equipment |
|
|
(13,037) |
(5,629) |
(31,133) |
|||
Interest received |
|
|
|
|
676 |
2,033 |
10,933 |
|
Cash flows from investing activities |
|
|
(4,838,058) |
(5,192,061) |
(9,002,866) |
|||
Cash flows from financing activities |
|
|
|
|
|
|||
New mortgage loans raised (Net) |
|
|
2,590,777 |
3,994,264 |
22,868,788 |
|||
Repayment of loans |
|
|
|
|
(366,454) |
(216,178) |
(12,588,154) |
|
Directors' loan (net of costs) |
|
- |
- |
3,666,724 |
||||
Cash flows from financing activities |
|
|
2,224,323 |
3,778,086 |
13,947,358 |
|||
Net decrease in cash and cash equivalents |
|
|
(2,277,041) |
(1,262,647) |
4,319,004 |
|||
Cash and cash equivalents at 1 January |
|
|
2,455,257 |
(1,863,747) |
(1,863,747) |
|||
Cash and cash equivalents at closing |
|
|
178,216 |
(3,126,394) |
2,455,257 |
|||
Comprising: |
|
|
|
|
|
|
|
|
- Cash and cash equivalents |
|
|
|
178,216 |
245,252 |
2,519,518 |
||
- Bank overdrafts |
|
|
|
|
- |
(3,371,646) |
(64,261) |
|
- Total |
|
|
|
|
|
178,216 |
(3,126,394) |
2,455,257 |
CareCapital Group Plc
Notes to the accounts (Unaudited)
1. Basis of preparation
The interim report of the Groups results for the six months ended 30 June 2009 was approved by the Board on 30 September 2009.
The interim financial information has not been audited and does not constitute statutory accounts as defined under section 435 of the Companies Act 2006.
The interim financial statements have been prepared in accordance with applicable accounting standards and are consistent with those accounting policies adopted in the consolidated statutory accounts of CareCapital Group Plc for the year ended 31 December 2008, prepared under IFRS as adopted in the EU. The auditors' report on those accounts, which have been filed with the Registrar of Companies, was unqualified but did contain an Emphasis of Matter with respect of the ability of the Company and the Group to continue as a going concern. The auditors' report did not contain a statement under section 498(2) or 498 (3) of the Companies Act 2006.
In the Group's annual report and accounts, the Directors stated that additional working capital would be required to fund progress on several development projects, a number of funding options had been reviewed and negotiations were progressing to secure the required finance. Since then further options have presented themselves to the Board and are also under active review. The Directors continue to have reasonable expectations of securing funding which will enable the Group to meet its debt repayment, development programme and working capital requirements for a period in excess of twelve months.
Consequently, the financial statements have been prepared on a going concern basis. However, there can be no certainty that funding will be secured and this interim financial information does not contain any adjustments that might be necessary in the event that funding is not secured.
2. Changes in Accounting Policies
In the current financial year, the Group has adopted IAS 1, "Presentation of Financial Statements" (Revised).
"IAS 1 Presentation of Financial Statements (Revised)" includes the requirement to present a Statement of Changes in Equity as a primary statement and introduces the possibility of either a single statement of Comprehensive Income (combining the Income Statement and a Statement of Comprehensive Income) or to retain the income statement with a supplementary Statement of Comprehensive Income. The second option has been adopted by CareCapital Group Plc. As this standard is concerned with presentation only it does not have any impact on the results or net assets of the Group.
3. Loans from CareCapital Ltd to the Group's German operations
Since the inception of CareCapital Group's investment programme in Germany, CareCapital Ltd, the Group's main operating subsidiary, has advanced loans to German Group Companies in order to facilitate the growth of the property investment and development business in that geographical area. Until 1 January 2009, such loans were treated as short term working capital loans subject to repayment. They were denominated in Euros, and exchange rate risk was carried in the UK. Any gain or loss resulting from the conversion of the loans into sterling was taken to the income statement. During January 2009, the Directors reviewed the outstanding loans and determined that it would be more appropriate to treat them as long term loans of a "quasi equity" nature. Consequently, the loans were fixed in Euros at the exchange rate applicable at 31 December 2008, and exchange rate risk passed to the German legal entities. For accounting periods after 1 January 2009 any exchange rate gains or losses arising from the translation of the German operations to sterling, will be shown in the statement of comprehensive income.
4. Investment Property valuations
At 30 June 2009 the Group's investment properties were valued at £49,367,932 of which £26,795,854 related to the UK portfolio and £22,572,078 related to the German properties after conversion to sterling from euros at an exchange rate of 1.17357. These values reflect the underlying position at 31 December 2008 uplifted for one rent review agreed during the period. The revaluation exercise referred to in the Chairman's statement reflected a small increase on a like for like basis, which has not been booked to the accounts.
5. Earnings per Share |
|
|
|
|
|
|
|
|
|
|
|
|
Six months |
Six months |
Year |
|
|
|
|
|
ended |
ended |
ended |
|
|
|
|
|
30 June |
30 June |
31 December |
|
|
|
|
|
2009 |
2008 |
2008 |
Basic earnings per share |
|
|
|
|
|
||
|
|
|
|
|
|
|
|
Basic earnings per share is calculated by dividing the profit |
|
|
|
||||
attributable to equity holders of the Company by the weighted |
|
|
|
||||
average number of ordinary shares in issue during the year, |
|
|
|
||||
|
|
|
|
|
|
|
|
(Loss) / profit attributable to equity holders of the Company (£) |
(56,795) |
(56,795) |
(1,688,027) |
||||
Weighted average number of ordinary shares in issue (thousands) |
76,754 |
76,754 |
76,754 |
||||
(Loss) / earnings per share (pence per share) |
|
(0.09) |
(0.09) |
(2.20) |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
Diluted earnings per share |
|
|
|
|
|
||
|
|
|
|
|
|
|
|
The Company has two categories of dilutive potential ordinary shares - share options and warrants. A calculation is |
|||||||
undertaken to determine the number of shares which could have been acquired at fair value based on the |
|||||||
monetary value of the subscription rights attached to outstanding share options. It is compared with the |
|||||||
number of shares which would have been issued assuming the exercise of the share options. |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months |
Six months |
Year |
|
|
|
|
|
ended |
ended |
ended |
|
|
|
|
|
30 June |
30 June |
31 December |
|
|
|
|
|
2009 |
2008 |
2008 |
|
|
|
|
|
|
|
|
(Loss) / profit attributable to equity holders of the Company (£) |
(56,795) |
(56,795) |
(1,688,027) |
||||
Weighted average number of ordinary shares in issue (thousands) |
76,754 |
76,754 |
76,754 |
||||
Adjustment for share options (thousands) |
|
- |
- |
- |
|||
Weighted average number of ordinary shares for diluted |
|
|
|
||||
earnings (thousands) |
|
|
|
76,754 |
76,754 |
76,754 |
|
Diluted (Loss) / earnings per share (pence per share) |
|
(0.09) |
(0.09) |
(2.20) |
|||
|
|
|
|
|
|
|
|
6. Availability of Results
These results are available on the Company's website, www.carecapital.co.uk